Optum Rx is nixing reauthorization requirements for more than 60 additional medications. | The PBM giant's list of drugs ...

Employers looking to continue investing in their well-being programs are eyeing services targeting behavioral health and women’s health, a new survey shows. Optum surveyed 544 employers in three ...

Optum is responding to the need to address behavioral health by expanding the availability of telehealth visits, including growing the number of providers available to see patients virtually. By the ...

In this webinar, our panelists will explore the unique challenges of measuring the impacts of behavioral health treatment and how a coordinated provider enablement strategy can bolster success.

Former Optum exec joins healthcare VC firm Trip Hofer, the former CEO of Optum Behavioral Health Solutions, joined healthcare venture capital firm .406 Ventures as a venture partner.

CVS Health Ventures has also been busy investing in digital health companies. In January, CVS Health Venture invested $100 million in Carbon Health, a hybrid healthcare company focused on primary and ...

There has been a surge in digital mental health solutions, making it difficult to know which ones are effective. One Optum exec weighed in on how she's managing this challenge.

UnitedHealth Group’s Optum subsidiary saw a lower operating margin in the second quarter due to more seniors getting care, a spike in demand for behavioral health services, and an influx of ...

UnitedHealthcare, one of the largest insurers in Washington, is facing a $500,000 fine for failing to prove its operations are in line with laws outlining mental and behavioral health coverage ...

Harnessing Technology Can Lead to More Mental Health Care Options, Expert Says This Mental Health Awareness Month, we speak with a behavioral health expert dedicated to fostering innovative digital ...

Optum Rx has added more than 60 additional drugs to a list for which it is eliminating reauthorization requirements, ...

Optum Rx officials said they now have eliminated reauthorization requirements for more than 140 chronic disease medications.